Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

This report compares the immunogenicity and kinetics of responses to third doses of vaccines from day (D) 28 to D242 following third doses in seven study arms.

Source: Journal of Infection - April 19, 2023 Category: Infectious Diseases Authors: Xinxue Liu, Alasdair P S Munro, Annie Wright, Shuo Feng, Leila Janani, Parvinder K Aley, Gavin Babbage, Jonathan Baker, David Baxter, Tanveer Bawa, Marcin Bula, Katrina Cathie, Krishna Chatterjee, Kate Dodd, Yvanne Enever, Lauren Fox, Ehsaan Qureshi, Anna Source Type: research